Aligos Therapeutics, Inc. - stock earnings
ALGS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -27.9 million USD | 2.7 million USD |
| 2023Q3 | -18.0 million USD | 3.2 million USD |
| 2023Q2 | -18.8 million USD | 6.9 million USD |
| 2023Q1 | -23.0 million USD | 2.7 million USD |
| 2022Q4 | -21.9 million USD | 3.5 million USD |
| 2022Q3 | -18.6 million USD | 4.1 million USD |
| 2022Q2 | -19.9 million USD | 3.7 million USD |
| 2022Q1 | -35.6 million USD | 2.6 million USD |
| 2021Q4 | -37.7 million USD | 367000 USD |
| 2021Q3 | -33.1 million USD | 1.5 million USD |
| 2021Q2 | -29.8 million USD | 1.5 million USD |
| 2021Q1 | -27.7 million USD | 910000 USD |
| 2020Q4 | -34.4 million USD | -10.5 million USD |
| 2020Q3 | -33.3 million USD | 2.0 million USD |
| 2020Q2 | -20.8 million USD | ? USD |
| 2020Q1 | -20.0 million USD | ? USD |
| 2019Q4 | -18.2 million USD | ? USD |
| 2019Q3 | -14.1 million USD | ? USD |
| 2019Q2 | -13.1 million USD | ? USD |
| 2019Q1 | -13.1 million USD | ? USD |
| 2018Q4 | -13.1 million USD | ? USD |
| 2018Q2 | -3.5 million USD | ? USD |
| 2018Q1 | -3.5 million USD | ? USD |
| 2017Q4 | -3.5 million USD | ? USD |
ALGS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -87.7 million USD | 15.5 million USD |
| 2022 | -96.0 million USD | 13.9 million USD |
| 2021 | -128.3 million USD | 4.4 million USD |
| 2020 | -108.5 million USD | -10.5 million USD |
| 2019 | -52.3 million USD | ? USD |
| 2018 | -13.9 million USD | ? USD |
ALGS
Price: $0.85
52 week price:
Earnings Per Share: -1.36 USD
P/E Ratio: -0.38
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 78576
Market Capitalization: 81.0 million